Latest Bevacizumab Stories
DALLAS, January 23, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced
Exploratory Analysis of Phase 2 Trial Shows Earlier and Sustained Responses in Patients Treated With Vectibix Versus Bevacizumab THOUSAND OAKS, Calif., Jan.
-- DIG-KT is a novel bi-specific mAb targeting VEGFR2 and Tie-2 pathways for treating cancers SHENYANG, China and DAEJEON, South Korea, Jan. 14, 2015 /PRNewswire/ -- 3SBio Inc.
Aldoxorubicin Shows a Complete Response, Tumor Shrinkage, Prolonged Stable Disease, and Favorable Tolerability in Patients LOS ANGELES, Jan.
ReportsnReports.com adds "Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023" to its store.
ReportsnReports.com adds “Colorectal Cancer – US Drug Forecast and Market Analysis to 2023” to its store.
RnRMarketResearch.com adds “Nintedanib (Colorectal Cancer) – Forecast and Market Analysis to 2023” to its store.
- A poem in which the author retracts something said in an earlier poem.